You are here

  • Home
  • Archive
  • Volume 7, Issue 1
  • Targeting interferon signaling and CTLA-4 enhance the therapeutic efficacy of anti-PD-1 immunotherapy in preclinical model of HPV+ oral cancer

Article metrics

Article menu

Download PDFPDF

XML
Research Article
Targeting interferon signaling and CTLA-4 enhance the therapeutic efficacy of anti-PD-1 immunotherapy in preclinical model of HPV+ oral cancer

 

Online download statistics by month:

Online download statistics by month: January 2020 to February 2026

AbstractFullPdf
Jan 2020660
Feb 202046460
Mar 202056563
Apr 202021214
May 202033339
Jun 2020414114
Jul 2020191918
Aug 2020393936
Sep 2020666644
Oct 2020616159
Nov 2020494843
Dec 2020616130
Jan 2021535346
Feb 2021585838
Mar 2021868654
Apr 2021666649
May 2021535333
Jun 2021626244
Jul 2021565639
Aug 2021737350
Sep 2021686851
Oct 2021636362
Nov 2021616162
Dec 2021969781
Jan 2022808554
Feb 2022838870
Mar 2022767659
Apr 202210711587
May 202211812661
Jun 2022717743
Jul 2022788251
Aug 2022606343
Sep 2022788457
Oct 20229010369
Nov 202214314668
Dec 202211811962
Jan 2023828246
Feb 2023868751
Mar 202311411565
Apr 2023727229
May 2023949576
Jun 2023878755
Jul 2023474729
Aug 2023616132
Sep 2023464631
Oct 2023646432
Nov 2023858528
Dec 2023636345
Jan 2024444540
Feb 2024545637
Mar 2024464874
Apr 2024495239
May 2024525242
Jun 2024434323
Jul 2024717420
Aug 2024434529
Sep 2024323228
Oct 2024374033
Nov 2024717240
Dec 2024767749
Jan 2025454528
Feb 2025616139
Mar 2025666637
Apr 2025646432
May 2025838444
Jun 2025333321
Jan 2026110
Feb 2026100
Total426843512767